Immutep
| Use attributes for filter ! | |
| Stock price | IMM |
|---|---|
| Disclaimer | |
| Headquarters | New South Wales |
| Australia | |
| Founded | 2001 |
| Key people | Frédéric Triebel |
| Marc Voigt | |
| Subsidiaries | Immutep S. A. |
| Cancer Vac Pty Ltd | |
| Oncomab, Ltd. | |
| Panvax Ltd. | |
| Date of Reg. | |
| Date of Upd. | |
| ID | 2986434 |
About Immutep
Immutep Ltd is a biotechnology company working primarily in the field of cancer immunotherapy using the LAG3 immune control mechanism. The company was originally built on CVac, a therapeutic cancer vaccine. In late 2014 the privately held French immunotherapy company Immutep SA was purchased by Prima Biotech.